MABC531 Sigma-AldrichAnti-Somatotropin/GH1 Antibody, clone 1H1.1
Anti-Somatotropin/GH1 Antibody, clone 1H1.1 is an antibody against Somatotropin/GH1 for use in Western Blotting.
More>> Anti-Somatotropin/GH1 Antibody, clone 1H1.1 is an antibody against Somatotropin/GH1 for use in Western Blotting. Less<<Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
Species Reactivity | Key Applications | Host | Format | Antibody Type |
---|---|---|---|---|
H | WB | M | Purified | Monoclonal Antibody |
References |
---|
Product Information | |
---|---|
Format | Purified |
Presentation | Purified mouse monoclonal IgG1κ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
Quality Level | MQ100 |
Applications | |
---|---|
Application | Anti-Somatotropin/GH1 Antibody, clone 1H1.1 is an antibody against Somatotropin/GH1 for use in Western Blotting. |
Key Applications |
|
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
Packaging Information | |
---|---|
Material Size | 100 μg |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
MABC531 | 04055977170665 |
Documentation
Anti-Somatotropin/GH1 Antibody, clone 1H1.1 Ficha datos de seguridad (MSDS)
Título |
---|
Anti-Somatotropin/GH1 Antibody, clone 1H1.1 Certificados de análisis
Cargo | Número de lote |
---|---|
Anti-Somatotropin/GH1, clone 1H1.1 3948896 | 3948896 |
Anti-Somatotropin/GH1, clone 1H1.1 - 3477806 | 3477806 |
Anti-Somatotropin/GH1, clone 1H1.1 -Q2573148 | Q2573148 |
Licencias necesarias e Información técnica
Cargo |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |